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Abstract
Background: Multiplex cytokine profiling systems are useful tools for investigating correlates of protective
immunity. Several Luminex and flow cytometry methods are commercially available but there is limited
information on the relative performance of different kits. A series of comparison experiments were carried out to
determine the most appropriate method for our subsequent studies.
Methods: Two Luminex methods were compared, the Bio-Rad human 17-plex panel and the Invitrogen (formerly
BioSource) human cytokine 10-plex kit, and two flow cytometry methods, the Becton Dickinson Human Th1/Th2
Cytokine Kit (CBA) and the Bender MedSystems Human Th1/Th2 11plex FlowCytomix Multiplex Kit. All kits were
tested for the measurement of cytokines in supernatants collected from human leukocytes stimulated with viable
Plasmodium falciparum infected red blood cells (iRBC) or P. falciparum schizont lysates.
Results: Data indicated that the kits differed in sensitivity and reproducibility depending on the cytokine, and
detected different quantities of some cytokines. The Bio-Rad 17-plex kit was able to detect more positive responses
than the Invitrogen 10-plex kit. However, only when detecting IL-1, IL-6 or TNF did the two Luminex based
methods correlate with one another. In this study, the flow cytometry based techniques were less variable and
correlated better with one another. The two flow cytometry based kits showed significant correlation when
detecting IFN-g, IL-2, TNF, IL-10 and IL-6, but overall the BD kit detected more positive responses than the Bender
MedSystems kit.
Conclusions: The microsphere suspension array technologies tested differed in reproducibility and the absolute
quantity of cytokine detected. Sample volume, the number of cytokines measured, and the time and cost of the
assays also differed. These data provide an accurate assessment of the four techniques, which will allow individual
researchers to select the tool most suited for their study population.
Background
Cells from both the adaptive and innate arms of the
immune system secrete small proteins known as cyto-
kines. These proteins are essential to the function of the
human immune system. Cytokines perform their actions
by binding to cell surface receptors, triggering a signal
cascade leading to the modification of gene expression.
Thus, the release of cytokines can have direct action on
cells. Cytokines can stimulate or inhibit cell activation,
they can promote proliferation, direct migration, induce
death, and promote cell maturation [1]. Knowledge of
the type and quantity of cytokine present during an
infection can help us to understand important mechan-
isms involved in immunity and can give clues as to the
type of cells present.
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immune correlate of protection has not yet been identi-
fied. Protection may be determined by a number of dif-
ferent parameters that may be present at different
moments before exposure and during disease progres-
sion. Multiplex cytokine profiling systems enable the
quantification of many different proteins within a liquid
phase sample and therefore can be a useful tool in iden-
tifying correlates of protective immunity and in charac-
terizing disease progression and immune responses.
Multiplex techniques can measure many different para-
meters within a small amount of sample material simul-
taneously thereby reducing any inter-assay variation,
sample material, analysis time, cost and human error.
Multiplex systems are especially useful tools in large
cohort studies where many samples need to be pro-
cessed, or when testing scarce material such as samples
collected from neonates [2,3].
A number of commercial kits are available. However,
limited data have been published comparing the relative
performance of these methods; it is not clear what is the
most robust and cost-effective choice. The purpose of
this study was to compare four different multiplex
methods to determine whether there is inherent varia-
tion between them and also to determine which kit per-
forms the best in terms of sensitivity and reproducibility
for the detection of cytokines produced in the superna-
tants of human peripheral blood mononuclear cells
(PBMC) stimulated with Plasmodium falciparum anti-
gens. This paper sets out to describe and evaluate two
different methods of multiplex cytokines analysis, lumi-
nex and flow cytometry, and to compare the perfor-
mance of two different manufacturers within each
method. The Bio-Rad human 17-plex panel and the Bio-
Source human cytokine 10-plex panel (now supplied by
Invitrogen) were tested for the Luminex 100 system.
The Becton Dickinson (BD) Human Th1/Th2 Cyto-
metric Bead Array (CBA) Kit and the Bender MedSys-
tems Human Th1/Th2 11plex FlowCytomix Multiplex
Kit were tested for the flow cytometry-based method.
Differences in sensitivity and reproducibility were
observed depending on the method used and even the cyto-
kine detected. In addition, when selecting the appropriate
multiplex cytokine profiling method, other factors were
important to consider such as amount of sample needed to
run the assay, the number of cytokines measured with each
kit, and the time and cost of the assays. This study provides
useful information to guide the selection of the appropriate
microsphere suspension array technology.
Methods
Volunteers
PBMC were collected from malaria naïve donors at the
blood bank in Hospital Clinic, Barcelona, Spain (2008),
and from healthy adults who had grown up in a malaria
endemic area, at the Centro de Investigaçao em Saude
da Manhiça (CISM), Manhiça, Mozambique (2005-
2006). Written informed consent was obtained from the
volunteers. Ethics Committees of Mozambique (refer-
ence 28/CNBS/04) and Hospital Clínic, Barcelona, Spain
(references 2004/2048, 2008/4376) reviewed and
approved the study.
Both malaria naïve and malaria exposed PBMC were
tested to be representative of the studies conducted in
the laboratory, including adaptive immune responses in
exposed individuals and innate immune responses in
naïve volunteers. In addition, there were limited cell
numbers in exposed individuals and the inclusion of
naïve volunteers (subject to less blood volume restric-
tions) allowed obtaining sufficient amounts of superna-
tant samples for all the analyses.
PBMC isolation and stimulation
Both live P. falciparum infected trophozoite stage red
blood cells (iRBC) and P. falciparum schizont extract
were used as antigen stimuli. iRBC induce a better
response and are the preferred stimulus when logisti-
cally possible (e.g. naïve volunteers in Barcelona). In
Manhiça, it is not feasible to have continuous produc-
tion of fresh iRBC from in vitro cultures, therefore, schi-
zont lysates were used for the cell stimulations.
PBMC from the malaria naïve subjects were isolated
using a Lymphoprep (Axis Shield) gradient and frozen
down in foetal calf serum (FCS) (Invitrogen) with 10%
DMSO (Sigma). Before analysis, the PBMC were
thawed in complete medium: RPMI 1640 with 10%
FCS, 100 IU/ml penicillin, 0.1 mg/ml streptomycin (all
Sigma, Poole, UK), and 2 mM l-glutamine (GIBCO/
Invitrogen, Paisley, UK) with 25 U/ml Benzonase
nuclease (Novagen). Two hundred thousand cells were
then stimulated for 24 h, 48 h or 72 h with 600,000
live P. falciparum infected trophozoite stage iRBC pre-
viously purified using Miltenyi Biotec (CA) Vario
MACS CS magnetic separation columns (98% enrich-
ment). The kinetics of the various cytokines tested
were not known a priori, therefore, the multiple time
points were used to capture the peaks of concentra-
tions for the different cytokines. Following the incuba-
tion period, the cells were centrifuged and the
supernatant collected and frozen at -80°C.
PBMC from malaria exposed Mozambican volunteers
were isolated using a Lymphoprep gradient and resus-
pended in complete medium. A total of 1.2 million fresh
PBMC were stimulated with 20 μlo faP. falciparum
(3D7 strain) schizont extract corresponding to lysate
from 2 million synchronized iRBC. The supernatant was
collected following incubation for 48 h or 72 h then fro-
zen at -80°C and shipped to Barcelona for analysis.
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Supernatants were thawed a n da n a l y s e dw i t ht h em u l -
tiplex cytokines detection systems. All methods were
carried out using the kits that were commercially avail-
able in 2007 and according to the manufacturer
instructions. The Invitrogen Human cytokine 10-plex
panel and the Bio-Rad experiments were carried out in
t h ep r e s e n c eo far e p r e s e n t a tive from the respective
manufacturers. All data were analysed as recom-
mended by the manufacturers.
Luminex
The Luminex system uses microsphere or bead sets
marked with differing ratios of two different fluoro-
phores, conjugated with monoclonal antibodies specific
for different cytokines or chemokines. In the assay, once
the cytokine of interest has bound, a secondary detec-
tion antibody specific for the cytokine or chemokine of
interest was added. The beads were read on a Luminex
machine (Bioplex-100, Bio-Rad) which has two lasers,
one that can identify the bead, and thus the cytokine or
chemokine it is specific for, and one that can detect the
quantity of the detection agent on the bead, and thus
the quantity of the cytokine or chemokine.
A serial dilution of the standards for the standard
curve was added to the plate in duplicate. Following the
generation of a five-parameterl o g i s t i cc u r v e ,t h es t a n -
dard recovery was calculated using the following equa-
tion: (observed concentration/expected concentration)
*100. A recovery range between 80-120% was recom-
mended by Bio-Rad, and a recovery range between 70-
130% was recommended by Invitrogen. Any sample that
fell on an area of the curve that was outside these
ranges was not considered accurate.
A positive sample was considered if it was above the
limits of detection as determined by the manufacturer.
The supplementary table shows the mean limits of
detection for the Bio-Rad and Invitrogen Kits.
Flow cytometry
To distinguish bead populations in the flow-based meth-
ods, the BD assay uses beads that are stained with dif-
ferent quantities of two fluorochromes, and the Bender
MedSystems method distinguishes the beads first by
size, then by quantities of a single fluorochrome. Mono-
clonal antibodies specific to one cytokine or chemokine
are conjugated to the surface of the beads. When the
cytokine or chemokine of interest has bound, a second-
ary antibody and detection fluorochromes are conju-
gated to enable cytokine detection. All samples were
acquired and analysed on a FACS Canto II (BD).
The standard curve for the BD CBA assay was deter-
mined using a five-parameter logistics model as with the
other assays. The data was analysed with FCAP Array
software provided by BD. To determine the standard
recovery range the following method was used as
recommended by BD:
A cut off (CO) value was calculated using the follow-
ing equation = [a + log MFI(NS)] * b + [c + log MFI
(PS)] * d
where: MFI(NS) = the median mean fluorescence
intensity of the negative control
MFI(PS) = the median mean fluorescence intensity
of the positive control
a, b, c, d are constants (FCAP Array software BD
v1.0.1 for windows)
A regression coefficient was then used to determine
the fit to the standard curve. The standard curve must
have an R-square value of over 98%.
The standard curve and recovery range for the Bender
MedSystems assay was determined in the same way as
the Invitrogen and Bio-Rad assays outlined above. The
recovery range recommended by Bender MedSystems
for this assay was between 70-130%. Any sample that
fell on an area of the curve that was outside the
accepted recovery range was not considered accurate.
A positive sample was considered if it was above the
detection limit for each analyte as determined by the
manufacturers. The detection limits are listed in the
supplementary table.
Statistical analysis
The values of the cytokine responses were positively
skewed, therefore, logarithms were taken of the data
prior to analysis. The resulting data were normally dis-
tributed. A test of mean differences was performed on
the log-transformed data [4]. This involves calculating
the difference between the values (between duplicate
plates or between different manufacturers for other
comparisons), for each sample in turn. The mean (and
its 95% confidence interval, CI) of these differences for
each sample were calculated. Both of these were then
transformed back onto the original scale by anti-log-
ging, to get a ratio change in the raw cytokine
responses, which for the mean, is then converted into
a percentage change. The percentage differences in
cytokine responses were a measure of bias (or systema-
tic differences) between the manufacturers (or two
plates). An assessment of whether or not there was
some association between measurements by one manu-
facturer compared to measurements by the other man-
ufacturer (or plate) was done by the Spearman Rank
correlation coefficient and its associated p-value; signif-
icant negative correlations were deemed implausible
and therefore likely to be due to chance. To test if
there were significant differences between the amounts
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rank test was used.
Results
Bio-Rad human 17-plex panel kit
Variability between plates
Plate-to-plate variability was tested only with the Bio-
Rad human 17-plex panel kit due to limitations in sam-
ple volumes. Thirty-two samples from malaria exposed
volunteers stimulated with P. falciparum schizont lysate
for 48 h or 72 h were tested on the same day with the
same operators in the presence of a Bio-Rad representa-
tive. The number of positive samples detected by each
duplicate plate is shown in Table 1. In 14 of the 17
cytokines tested, a difference in the number of positive
responses was detected between the duplicate assays.
Concordance between the two plates was investigated
in the positive samples. Table 2 gives the Spearman’s
Rho correlation, the geometric mean (GM) for each
plate and the percentage difference in GM (95% CI).
The correlation between the two plates differed depend-
ing on the cytokine tested. IL-2 and IL-6 showed the
best correlation (Spearman’sR h o=0 . 9 6f o rI L - 2a n d
0.95 for IL-6, both with P = 0.0001). TNF, IFN-g and
IL-5 did not significantly correlate with one another.
Scatter graphs of Plate 1 and Plate 2 for all the cyto-
kines are shown in Additional file 1. The percentage dif-
ference in GM between the two plates also varied
depending on the cytokine measured. A 162% difference
between the two plates was detected in the 15 MIP-1b
positive samples even though the two plates significantly
correlated with one another. This suggested that plate 1
detected much higher amounts of this chemokine than
plate 2. IL-5, IL-13 or IFN-g showed a lower percentage
difference in GM; 14%, 18% and 18% respectively (Table
2). The mean plate-to-plate variability (% difference in
GM between duplicates) was 44%.
Bio-Rad human 17-plex panel kit and Invitrogen human
cytokine 10-plex panel Comparisons
The sensitivity of the Bio-Rad kit was compared to the
Invitrogen kit using 17 supernatant samples from PBMC
isolated from Mozambican volunteers and stimulated
with P. falciparum schizont lysate for 48 h or 72 h. Table
3 shows the number of positive samples detected in Bio-
Rad and Invitrogen assays. The Bio-Rad assay detected a
greater number of overall positive responses than the
Invitrogen assays (88 and 57 respectively). The Invitrogen
kit failed to detect any IL-4, IL-5, IL-8 or IFN-g in any of
the samples. The Bio-Rad kit detected at least 1 positive
response for all the cytokines apart from IL-8. The Invi-
trogen kit however did detect a larger number of positive
responses than the Bio-Rad kit for GM-CSF and IL-6
despite having a higher limit of detection (according to
the manufacturers: Bio-Rad = 2.2 pg/ml GM-CSF, Invi-
trogen = 15 pg/ml GM-CSF, Bio-Rad = 2.6 pg/ml IL-6
Invitrogen = 3 pg/ml IL-6 as shown in Additional file 2).
A Spearman’s Rho test showed that within the three
cytokines where enough positive responses were
detected to enable statistical comparisons (IL-1, IL-6
and TNF), the two kits significantly correlated with one
another in the detection of IL-1 and IL-6 but not TNF
(Table 4 and Figure 1). The GM of both IL-1 and IL-6
detected by the Invitrogen assay was higher than the
GM for the Bio-Rad assay. A Wilcoxon rank-sum test
for significance showed that these differences were sig-
nificant (Table 4). No significant difference in the quan-
tity of TNF detected by the two kits was seen.
BD CBA and Bender MedSystems FlowCytomix
Comparisons
The flow cytometry methods were compared using 73
supernatant samples collected from PBMC stimulated
with either P. falciparum schizont lysate or iRBC. The
number of positive responses detected by each kit is listed
in Table 5. The BD kit detected more positive responses
than the Bender MedSystems kit overall (204 and 160
respectively) but fewer positive responses for IFN-g and
IL-2. The BD kit detected many more positive responses
than the Bender MedSystems kit for IL-10 despite having
a higher cut off of sensitivity (BD = 2.8 pg/ml, Bender
MedSystems = 1.9 pg/ml as shown in Additional file 2).
For IL-2, the Bender MedSystems kit detected more
Table 1 Number of positive responses detected by the
Bio-Rad Plate 1 and Plate 2
Cytokine Plate 1 Plate 2
IL-1b 32/32 31/32
IL-2 17/32 12/32
IL-4 26/32 21/32
IL-5 8/32 11/32
IL-6 19/32 32/32
IL-7 3/32 4/32
IL-8 0/32 0/32
IL-10 8/32 30/32
IL-12p70 2/32 2/32
IL-13 26/32 19/32
Il-17 25/32 1/32
G-CSF 30/32 12/32
GM-CSF 0/32 1/32
IFN-g 19/32 4/32
MCP-1 0/32 0/32
MIP-1b 15/32 31/32
TNF 17/32 9/32
Total All Cytokines 247 220
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cut off (BD = 2.6 pg/ml, Bender MedSystems = 16.4 pg/ml
as shown in Additional file 2). This suggests that the sensi-
tivity cut off described by the manufacturer does not
reflect reality, and is not the reason samples are being
detected by one kit, but not the other.
All cytokines with enough positive observations to
enable a Spearman’sR h o( I L - 2 ,I L - 6 ,I L - 1 0 ,I F N - g and
TNF) showed there was a significant correlation
between the BD and the Bender MedSystems (Table 6).
However, at least a 29% difference in the GM between
the two assays was detected (Table 6). The correlation
between the two methods is graphically represented in
Figure 2 for IFN-g,I L - 2 ,I L - 6 ,I L - 1 0 ,a n dT N F .T h eB D
kit detected higher quantities of IL-6 and IL-10, whereas
the Bender MedSystems kit detected more IFN-g,I L - 2
and TNF (Table 6). A Wilcoxon signed rank test was
used to see if these differences were significant. The
Bender MedSystems kit detected significantly higher
amounts of IFN-g and TNF but significantly lower
a m o u n t so fI L - 6a n dI L - 1 0t h a nt h eB Dk i t .T h e r ew a s
no significant difference in IL-2 detection (Table 6).
Comparison between duplicate wells - all four methods
Table 7 shows the Spearman’s Rho correlation between
duplicate wells that were tested within the Bio-Rad,
Invitrogen, Bender MedSystems and BD kits. The BD,
Bender MedSystems and Bio-Rad assays all appeared to
be robust and had good concordance between duplicate
wells (Spearman’sR h o>0 . 8 ) .T h eI n v i t r o g e na s s a yw a s
more variable with lower concordance between dupli-
cate wells for IFN-g, IL-2 and TNF.
Comparison of kit characteristics
When selecting an assay to use, other factors are impor-
tant to consider. Table 8 summarizes the four assays
Table 2 Comparisons between two identical plates tested with the Bio-Rad Human 17-plex cytokine panel
Cytokine Number of positive
observations
Spearman’s
Rho
GM (pg/ml) plate
1
GM (pg/
ml)
plate 2
% difference in GM (95% CI) between 2
plates
IL-1 b 31 0.88** 32.47 21.34 52 (32, 75)
IL-2 12 0.96** 30.86 43.76 29 (16, 41)
IL-4 19 0.63** 1.88 1.21 55 (35, 78)
IL-5 7 0.71
NS 2.16 2.52 14 (-23, 40)
IL-6 19 0.95** 345.36 248.76 38 (20, 60)
IL-10 8 0.86** 21.65 15.06 44 (-19, 155)
IL-13 18 0.86** 5.30 4.49 18 (-8, 52)
G-CSF 12 0.62* 118.08 51.06 131 (92, 179)
IFN-g 4 -0.60
NS 85.55 103.95 18 (-50, 55)
MIP-1b 15 0.89** 156.73 59.85 162 (117, 217)
TNF 9 -0.13
NS 61.10 40.35 51 (2, 126)
Spearman’s Rho was used to test if a significant correlation existed between the samples on the two plates. **= Spearman’s Rho test with significance of P <
0.01, * = Spearman’s Rho test with significance of P < 0.05,
NS = Spearman’s Rho test which is non-significant. The cytokines with too few positive observations
to enable spearman’s Rho tests were not included on this table. GM = geometric mean.
Table 3 Number of positive responses detected by the Bio-Rad and Invitrogen kits
Cytokine Bio-Rad Invitrogen Number (%) of concordant positive observations
IL-1b 17/17 17/17 17 (100%)
IL-2 10/17 1/17 1 (5.8%)
IL-4 15/17 0/17 0 (0%)
IL-5 5/17 0/17 0 (0%)
IL-6 7/17 16/17 7 (41.2%)
IL-8 0/17 0/17 0 (0%)
IL-10 9/17 1/17 1 (5.8%)
GM-CSF 1/17 13/17 1 (5.8%)
IFN-g 12/17 0/17 0 (0%)
TNF 12/17 9/17 9 (52.9%)
TOTAL all cytokines 88 57
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the study, number of cytokines detected, amount of
sample needed and time for assay completion.
Discussion
Four different multiplex cytokine detection kits from
different manufacturers were tested and compared in
their ability to detect human chemokines and Th1 and
Th2 cytokines in supernatants collected from human
PBMC stimulated with P. falciparum parasite antigens.
A comparison of all parameters across all four methods
in parallel with identical sets of supernatants and multi-
ple experiments was not possible because of sample
volume restrictions due to limitations in bleeding proto-
cols in the human field studies.
The Bio-Rad human 17-plex Luminex kit was found
to be variable even when running the same samples on
t h es a m ed a y .T N F ,I L - 5a n dI F N - g,w h e nd e t e c t e do n
duplicate plates, did not significantly correlate. A signifi-
cant difference in the quantity of some chemokines,
such as MIP-1b and G-CSF was also detected between
duplicate plates. The second Luminex-based method
tested, the Invitrogen 10-plex Luminex kit, was shown
to have low concordance between duplicate wells tested
on the same plate for some key cytokines: TNF, IL-2
and IFN-g (Table 7). These results suggest Luminex kits
tested in this study might be sensitive to the effect of
external factors such as temperature, pipetting and the
serum present in the media. Normal human serum has
been reported to reduce the sensitivity of some com-
mercial sources of antibody pairs [5], and the presence
of animal proteins such as bovine serum albumin can
also interfere with the assays. Heterophile antibodies
(antibodies able to cross phyla in their reactivity) and
human anti-animal antibodies can bind directly to
blocking protein causing elevated values, false-positive
results and high background [6].
When comparing the Bio-Rad kit to the Invitrogen kit,
the Bio-Rad kit was able to detect more positive
responses across all cytokines than the Invitrogen kit. A
correlation was only seen between the two kits in IL-1
and IL-6 detection. The Invitrogen kit did however
detect significantly higher quantities of IL-6 and IL-1
than the Bio-Rad kit. Siawaya et al compared three
commercial Luminex kits to ELISA assays for the detec-
tion of cytokines in whole blood, and reported some dif-
ferences in accuracy and correlations between different
kits. Notably, in their hands, the Bio-Rad human 17-plex
assay was shown to correlate less well with ELISA than
the other two kits tested (LINCO Inc’s 29-plex kit, and
RnD System’s Fluorokine-Multi Analyte Profiling (MAP)
base kit A and B) [7].
Table 4 Comparison of the Bio-Rad and Invitrogen kits
Cytokine Number of positive
observations
Spearman’s
Rho
GM (pg/ml)
Invitrogen
GM (pg/ml) Bio-
Rad
% difference in
GM
(95% CI)
Wilcoxon Signed Rank
Test
P value
IL-1b 17 0.6348** 185.86 48.51 283 (174, 436) 0.0004
IL-6 7 0.9286** 408.19 316.03 29 (-3, 73) 0.0008
TNF 9 -0.4017
NS 52.02 76.48 32 (-60,15) 0.09
Number of positive observation concordant between both assays with the Spearman’s Rho to test for significant correlations between the assays. **= Spearman’s
Rho test with significance of P =< 0.01, * = Spearman’s Rho test with significance of P =< 0.05,
NS = Spearman’s Rho test which in non-significant. Geometric
means (GM) of both assays with the % difference in the geometric means. The table also shows Wilcoxon Rank Sum Significant differences in the quantity of
cytokine detected in samples between the Bio-Rad and Invitrogen assays. GM = geometric mean.
Figure 1 Correlations between IL-1, IL-6 and TNF measured by Luminex.C o r r e l a t i o no fp g / m lo fI L - 1( A ) ,I L - 6( B )a n dT N F( C )d e t e c t e d
between the Bio-Rad and Invitrogen kits. The two kits significantly correlated with one another for the detection of IL-1 (Spearman’s Rho test
with significance of P < 0.01 = 0.6348) and IL-6 (Spearman’s Rho test with significance of P < 0.01 = 0.9286).
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also evaluated. The BD Human Th1/Th2 Cytokine kit
detected more cytokine-positive samples across all the
cytokines, but a significantly lower quantity of IL-6 and
IL-1 than the Bender MedSystems Human Th1/Th2
11plex FlowCytomix Multiplex kit. There was good con-
cordance between the two kits when detecting IFN-g,
IL-2, IL-6, IL-10 and TNF. The amount of IL-4 and IL-
12 in these samples was low and, therefore, neither kit
was able to detect any IL-4 or IL-12. The correlations
between the BD kit and Bender MedSystems kit infer
that these kits are more robust and less sensitive to
external factors than the Luminex-based kits tested.
Significant correlation in IL-6 detection was seen
between different kits with both the Luminex and flow
cytometry-based methods. These correlations could be
due to the high levels of IL-6 detected by all assays
insuring that the levels were well above the limits of
detection and the quantities more accurately deter-
mined. Khan et. al. compared four Luminex-based
methods for the detection of cytokines in serum and
also reported that the trends and concentrations of IL-6
detected did not ‘differ substantially’ across the kits, the
same was observed for IL-8 and TNF [8]. It is possible
that IL-6 antibodies are less affected by external factors
and bind more efficiently than other antibodies.
D i f f e r e n c e si nt h ea b s o l u t eq u a n t i t yo fc y t o k i n ep r e -
sent in the samples were detected when testing both the
Luminex and the flow cytometry systems. This has been
reported elsewhere with different commercially available
ELISA and multiplex kits [9-11]. Young et al compared
the BD kit, ELISA and Bender MedSystems kit in the
measurement of cytokines in rodent bronchoalveolar
lavage and reported that even though correlations can
be good between multiplex cytokine kits and ELISA, a
large fold difference (up to 11-fold) in the quantity of
cytokine detected can be seen [11]. Contaminants in the
matrix that differentially affect the standard curves and
efficiency of different monoclonal antibody pairing may
account for these differences.
These results have highlighted the differences that may
exist between multiplex microsphere suspension array
cytokine kits. It is important to be aware of the potential
differences in absolute cytokine measurements between
kits when comparing different samples tested with differ-
ent methods. The large variation seen between duplicate
plates (Bio-Rad) may require that rigorous standards be in
place to prove that data between plates are indeed compar-
able. Other factors such as cost, quantity of sample needed
and number of parameters measured are also important to
consider. In addition, sensitivity for each cytokine varies
within a multiplex kit and the final selection may be influ-
enced by which cytokines are of more interest. The Lumi-
nex assays offered a greater variety of cytokines than flow-
based methods, but in this study were more expensive and
more variable with the kits available at the time. Only two
of the several Luminex kits available for multiplex cytokine
analysis were tested, these kits are evolving and improve-
ments can be introduced. In the most recent Luminex kits,
availability of magnetic beads may decrease bead loss dur-
ing washes and increase the reproducibility and robustness
of the new Luminex-based kits.
Table 5 Number of positive responses detected with the
BD and the Bender MedSystems kits
Cytokine BD CBA Bender MedSystems
IFN-g 23/73 28/73
IL-2 19/73 29/73
IL-4 0/73 0/73
IL-6 73/73 70/73
IL-10 49/73 20/73
IL-12 0/73 1/73
TNF 47/73 44/73
TOTAL all cytokines 204 160
The two flow cytometry methods were compared using 73 supernatant
samples collected from PBMC stimulated with either P. falciparum schizont
lysate or iRBC
Table 6 Comparison of the BD and Bender MedSystems Kits
Cytokine Number of positive
observations
Spearman’s
Rho
GM (pg/
ml)
BD
GM (pg/ml)
Bender
Medsystems
% difference in GM between 2
plates (95% CI)
Wilcoxon signed
rank test
IFN-g 23 0.75** 80.00 145.69 45 (62, 21) 0.043
IL-2 13 0.86** 80.87 113.10 29 (57, 19) 0.339
IL-6 70 0.94** 867.64 433.89 99.9 (72,133) <0.0001
IL-10 20 0.88** 40.84 29.87 37 (-5, 96) 0.002
TNF 44 0.7** 36.83 56.64 35 (51, 13) 0.010
Number of positive observation concordant between both assays, with the Spearman’s Rho to test for significant correlations between the assays. **=
Spearman’s Rho test with significance of P < 0.01, * = Spearman’s Rho test with significance of P < 0.05,
NS = Spearman’s Rho test which in non-significant.
Geometric means of both assays with the % difference in geometric means. The table also shows Wilcoxon Rank Sum Significant differences in the quantityo f
cytokine detected in samples between the BD and Bender MedSystems kits. GM = geometric mean.
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Profiling systems are invaluable when there is a need
to screen many samples or cytokines, or when much
information is needed from a small amount of sample.
These data provide an accurate assessment of the four
techniques, which will allow individual researchers to
select the tool most suited for their malaria studies. It
is important to be aware of the potential differences
between the manufacturers before selecting a kit and
when comparing cytokine concentrations detected with
two different commercial kits. If more precise mea-
surement of the amount of a particular cytokine pre-
sent within a sample is needed, probably a different
method such as super-sensitive ELISA should be
considered.
Figure 2 Correlations between IFN-g, IL-2, TNF, IL-10 and IL-6 measured by Flow Cytometry. Scatter plots to show the correlation
between the BD and Bender MedSystems kits for IFN-g (A), IL-2 (B), TNF (C) IL-10 (D), IL-6 (E). The two kits significantly correlated with one
another for the detection of all cytokines (Spearman’s Rho test with significance of P < 0.01).
Table 7 Spearman’s Rho correlation between the
duplicates within the Bio-Rad, Invitrogen, BD and Bender
MedSystems kits
Cytokine Bio-Rad Invitrogen BD Bender MedSystems
IFN-g 0.97 0.77 0.99 0.96
IL-2 0.95 0.71 0.99 0.85
IL-6 0.95 0.94 0.94 0.98
IL-10 0.98 0.90 0.89 1
TNF 0.93 0.78 0.96 0.96
IL-4 0.96 0.83 No responses No Responses
IL-12p70 0.93 Not Done No responses No Responses
Mean 0.96 0.95 0.95 0.82
Table 8 Summary of the four assays
Measure Bio-
Rad
Invitrogen BD Bender
MedSystems
Cost (1 = highest cost) 2 1 3 4
Time taken for assay
completion
2h1 0
min
5h 4h 4h
Time taken for reading
samples
30 min 30 min 2 1/2
h
2 1/2 h
Mean correlation
(duplicate wells)
0.95 0.82 0.95 0.96
Number of cytokines
tested
17 10 11 7
Volume of sample
needed
100 μl 100 μl5 0 μl2 5 μl
The kits were compared in terms of cost, time for assay completion,
correlation between duplicate wells, variability, number of cytokines detected
and sample volume. Cost was based on quotes received from Spanish
distributers (2007).
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Additional file 1: Correlations between Bio-Rad plate one and plate
two. Scatter plots to show the correlations between IL-1, IL-2, IL-4, IL-5,
IL-6, IL-7, IL-17, IL-10, IL-12, IL-13, G-CSF, IFN-g and TNF on two duplicate
plates, run on the same day with the same samples.
Additional file 2: Supplementary Table: Kit Detection Limits.
Detection limits (pg/ml) provided by manufacturers for cytokines
detected in the Bio-Rad human 17-plex panel, the Invitrogen human
cytokine 10-plex panel, the BD human Cytometric Bead Array (CBA)
Human Th1/Th2 Cytokine Kit and the Bender MedSystems Human Th1/
Th2 11plex FlowCytomix Multiplex Kit. Cytokines not included in a
particular kit are marked ‘Not tested’.
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